Immunohistochemistry revealed that FR-β was expressed by both microglia and macrophages in EAE lesion; however, the different uptake of both tracers at 90 days suggests that [18F]FOL/FR-β imaging may be complementary of TSPO imaging in MS. This evidence concerns the gene TSPO and myeloid sarcoma.